Awesome post Musky, thanks. It’s all laid out in front of us now. Once we lock away Immunotherapies it will all be a matter of execution and innovation with 3D type products leading the way.
What a lot of investors don’t realise is that the blue sky for TAVR and TMVR is as big as any of our chances with Immunotherapies and so much more plausible and possible.
2018 has true potential to be big.
SP in one year?, page-7
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.15 |
Change
0.350(2.97%) |
Mkt cap ! $256.8M | |||
| Open | High | Low | Value | Volume |
| $11.80 | $12.15 | $11.21 | $376.0K | 32.22K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 139 | $12.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.15 | 830 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |